Simple question...is our industry risk averse? Some would say, "Yes, absolutely." Look at psychiatric drugs, as an example. When the SSRIs were launched in the early 1990s, it was a…
The recent news that Novartis is closing its Colorado-based generics manufacturing facility brought back a few memories. A company spokesperson blamed "above-average pricing pressure". The products were described as "oral...for…
Is out-licensing difficult? Yes, of course it is. But how difficult is it? Is this something which can be quantified? And, why would we want to quantify this anyway? These…